Interestingly, in hepatocarcinoma cells, miR-493-5p displayed anti-tumor activity by inhibiting the IGF2-derived intronic miR-483-3p, the expression of which correlates with IGF2-LOI in liver cancer cells [126]. The gene discussed is IGF2; the disease is liver cancer.